Is pretreatment with P2Y<inf>12</inf> inhibitors in Non-ST-segment-elevation acute coronary syndrome clinically justified?

2014

Circulation (Baltimore) , Volume 130 - Issue 21 p. 1891- 1903

Additional Metadata
Persistent URL	doi.org/10.1161/CIRCULATIONAHA.114.011319, hdl.handle.net/1765/89270
Journal	Circulation (Baltimore)
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Valgimigli, M. (2014). Is pretreatment with P2Y12 inhibitors in Non-ST-segment-elevation acute coronary syndrome clinically justified?. Circulation (Baltimore), 130(21), 1891–1903. doi:10.1161/CIRCULATIONAHA.114.011319

Publication